default author photo

Dana Marie Roque

University of Maryland, Baltimore (UMB)

SCHOLARLY PAPERS

1

DOWNLOADS

88

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Phase II Evaluation of the Efficacy and Safety of Sacituzumab Govitecan in Patients with Recurrent Uterine Cancer

Number of pages: 30 Posted: 05 Jan 2026
Yale University - School of Medicine, University of Maryland, Baltimore (UMB), University of Arkansas for Medical Sciences - Department of Biostatistics and Please see PDF for full list of authors & affiliations
Downloads 88

Abstract:

Loading...

sacituzumab govitecan, uterine cancer, endometrial cancer, Trop-2, uterine serous carcinoma, carcinossarcoma